• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Pathogens detected using a syndromic molecular diagnostic platform in patients hospitalized with severe respiratory illness in So

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2022 Jun 11;S1201-9712(22)00346-0.
doi: 10.1016/j.ijid.2022.06.011. Online ahead of print.
Pathogens detected using a syndromic molecular diagnostic platform in patients hospitalized with severe respiratory illness in South Africa in 2017


Malefu Moleleki[SUP] 1 [/SUP], Mignon du Plessis[SUP] 2 [/SUP], Kedibone Ndlangisa[SUP] 2 [/SUP], Cayla Reddy[SUP] 2 [/SUP], Orienka Hellferscee[SUP] 3 [/SUP], Omphe Mekgoe[SUP] 4 [/SUP], Meredith McMorrow[SUP] 5 [/SUP], Sibongile Walaza[SUP] 6 [/SUP], Cheryl Cohen[SUP] 6 [/SUP], Stefano Tempia[SUP] 7 [/SUP], Anne von Gottberg[SUP] 2 [/SUP], Nicole Wolter[SUP] 2 [/SUP]



Affiliations

Abstract

Objectives: We describe the use of a multi-pathogen platform, TaqMan array card (TAC) real-time PCR, for the detection of pathogens in patients hospitalized with severe respiratory illness (SRI).
Methods: Prospective hospital-based syndromic surveillance for acute and chronic SRI was carried out at two sentinel sites in South Africa between January and December 2017. We tested respiratory specimens for 21 respiratory pathogens and blood samples for nine bacteria using TAC. Pathogen detection was compared by age group and HIV status using the chi-squared test.
Results: During 2017, 956 patients of all ages were enrolled in the SRI surveillance, and of these, 637 (67%) patients were included in this study (637 blood, 487 naso- and oro-pharyngeal swabs and 411 sputum specimens tested). At least one pathogen was detected in 83% (527/637) of patients. Common pathogens detected included H. influenzae (225/637; 35%), S. pneumoniae (224/637; 35%), rhinovirus (144/637; 23%), S. aureus (129/637; 20%), K. pneumoniae (85/637; 13%), M. tuberculosis (75/637; 12%), and respiratory syncytial virus (57/637; 9%). Multiple pathogens (≥2) were co-detected in 57% (364/637) of patients.
Conclusion: While use of a multi-pathogen platform improved pathogen yield, pathogen co-detections were common and would need clinical assessment for usefulness in individual-level treatment and management decisions.

Keywords: Taqman array card; community-acquired pneumonia; real-time PCR; severe respiratory illness.
 
Back
Top Bottom